Saudi Food & Drug Authority

What Saudi Food & Drug Authority does

The Saudi Food and Drug Authority (SFDA) is an independent government regulatory authority established in 2003 and headquartered in Riyadh, Saudi Arabia, operating under Saudi Vision 2030 with direct accountability to the President of the Council of Ministers. SFDA holds exclusive jurisdiction over the safety, quality, and regulatory compliance of food, drugs, medical devices, cosmetics, pesticides, feeds, tobacco, and halal products consumed or used in the Kingdom. It licenses establishments, conducts inspections, issues product approvals and recalls, and operates national reference laboratories.

SFDA delivers its regulatory mandate through a portfolio of digital platforms, including a comprehensive e-Services Portal, the Rased national drug tracking system, an Electronic Controlled Drugs System for Hajj-related permits, a Customer Journey Portal for guided regulatory workflows, and the SFDA Evaluation Program for food and cosmetic establishments. Underlying technology includes AI, robotic process automation, and data analytics applied to chemical hazard assessment, pharmacovigilance, and medication error prevention. The authority also runs the Dammam Reference Laboratory, the first in the Middle East to validate analytical methods for detecting organofluorine compounds in food (ISO/IEC 17025 accredited), and launched the Saudi Pharmacopoeia in October 2025 with a dedicated Halal chapter. Q1 2026 enforcement activity alone covered 15,230 inspection visits across 12,260 facilities, resulting in 1,753 enforcement actions and the prevention of 1,057 tons of non-compliant food from entering the Kingdom.

As a government state entity, SFDA does not operate a commercial revenue model; it is funded by the Saudi government and may collect regulatory fees that are not publicly disclosed. Its "customers" in the broadest sense are the regulated industries it oversees and the Saudi public it protects. Strategic direction is shaped by Vision 2030 healthcare transformation and food security goals, with recent international outreach including partnerships with the FAO, the Egyptian Drug Authority (via ICMRA), and a 2026 US visit by CEO Dr. Hisham Aljadhey to study pharmaceutical innovation.

Name

Saudi Food & Drug Authority

Legal name

Saudi Food and Drug Authority (SFDA)

Website

https://sfda.gov.sa

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

The Saudi Food and Drug Authority (SFDA) is the Saudi government regulatory authority, headquartered in Riyadh, that licenses, inspects, and enforces safety standards for food, drugs, medical devices, cosmetics, pesticides, feeds, tobacco, and halal products under Vision 2030.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Food Regulatory Services

akta.pro primary industry

Food Industry Licensing, Registration & Compliance Audits (HLAJAEAG)

Keywords

• Pharmaceutical regulation
• Food safety oversight
• Medical device regulation
• Halal certification
• Regulatory compliance

Headquarters

HQ city

Riyadh

HQ country

Saudi Arabia

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Distribution channels1 record

Marketing channels4 records

Core offering

The Saudi Food and Drug Authority (SFDA) is Saudi Arabia's national regulatory body overseeing food safety, pharmaceuticals, medical devices, cosmetics, pesticides, animal feeds, tobacco, laboratories, and halal certification. It issues market authorizations, conducts inspections, enforces standards, and operates digital e-services platforms (including the Drug Tracking System "Rased" and Electronic Controlled Drugs System) for licensing, traceability, and compliance monitoring. The authority also operates ISO/IEC 17025-accredited reference laboratories and deploys AI, robotic process automation, and data analytics for regulatory efficiency.

Product overview

The Saudi Food and Drug Authority (SFDA) is a regulatory body overseeing food, drug, medical device, cosmetics, tobacco, pesticides, feed, laboratories, and halal certification sectors. SFDA provides regulatory services through e-portals including the drug tracking system (رصد), electronic controlled drugs system, and evaluation programs. The authority has embraced digital transformation with AI-powered solutions including computer vision for biomarker detection and process automation for regulatory efficiency. Key products include the Saudi Pharmacopoeia, reference laboratories (ISO/IEC 17025 accredited), and various electronic services for compliance management.

Differentiator

Problem solved

Functional benefit

Products and services

• E-Services Portal (البوابة الإلكترونية)

Quantifiable outcome

• Ranked 20th globally in UNIDO Quality Infrastructure Index
• +3 more outcomes

Segments1 record

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Food and Agriculture Organization (FAO)coreStrategic or Co-development Partner · 9 September 2025FAO partnered with SFDA to hold the Hack4SaferPlates hackathon at SFDA headquarters in Riyadh, bringing together innovators, practitioners, and policymakers to address food safety challenges across the NENA region. Winning teams enter a six-month incubation programme with potential presentation at FAO's Science and Innovation Forum in Rome.
• Oxford Business GroupcoreStrategic or Co-development PartnerOxford Business Group published a six-part article series in collaboration with SFDA examining Saudi Arabia's regulatory reform and digital innovation across food safety, healthcare, and biotechnology.
• Egyptian Drug AuthoritycoreStrategic or Co-development PartnerBilateral meeting between the Chairperson of the Egyptian Drug Authority and SFDA President Hisham Aljadhey during the 2025 ICMRA Summit in Amsterdam to review cooperation progress, digital transformation, and AI in pharmaceutical regulation.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• U.S. Food and Drug Administration (FDA): The U.S. FDA is the global benchmark for national food and drug regulation, overseeing food safety, pharmaceuticals, medical devices, and cosmetics in the world's largest healthcare market. It is the most direct functional peer to SFDA given identical scope (food, drugs, devices, cosmetics) and similar regulatory authority.
• European Medicines Agency (EMA): EMA is the EU's central medicines regulatory authority, evaluating and supervising pharmaceutical products across EU member states. It is a direct peer to SFDA in drug approval processes and is a frequent benchmark referenced in SFDA's international cooperation efforts.
• UK Medicines and Healthcare products Regulatory Agency (MHRA): MHRA regulates medicines, medical devices, and blood components for transfusion in the UK. It shares SFDA's comprehensive scope across drugs and medical devices and is comparable in operating model as a national post-Brexit standalone regulator.
• Health Canada: Health Canada is the federal department responsible for national health policy and pharmaceutical/medical device regulation in Canada. Comparable to SFDA in scope (food, drugs, devices, cosmetics) and as a national-level regulator serving a similar-sized economy.
• Australian Therapeutic Goods Administration (TGA): TGA regulates therapeutic goods including prescription medicines, vaccines, medical devices, and cosmetics in Australia. It shares SFDA's mandate across drugs, devices, and cosmetics and is often compared to other national regulators for approval pathway design.
• Japan Pharmaceuticals and Medical Devices Agency (PMDA): PMDA is Japan's regulatory agency for pharmaceuticals and medical devices, providing scientific reviews and post-market safety monitoring. It mirrors SFDA's drug and device focus and is comparable in operating sophisticated digital approval systems.
• China National Medical Products Administration (NMPA): NMPA regulates drugs, medical devices, cosmetics, and food in China, with rapidly modernizing approval pathways. Comparable to SFDA in scale and as a national regulator driving pharmaceutical market access in a major economy.
• Germany Federal Institute for Drugs and Medical Devices (BfArM): BfArM is Germany's federal regulator for medicinal products and medical devices, operating within the EU framework. It is a direct peer to SFDA's drug and device regulatory functions with comparable technical depth and laboratory capabilities.

Regional players

• Egyptian Drug Authority (EDA): EDA is Egypt's national pharmaceutical regulator and an active bilateral partner of SFDA (formal cooperation at the 2025 ICMRA Summit). It is a regional peer in the MENA pharmaceutical regulatory landscape with similar Vision-aligned transformation goals.
• Singapore Health Sciences Authority (HSA): HSA regulates health products including pharmaceuticals, medical devices, cosmetics, and food in Singapore. It is a regional peer to SFDA with comparable scope across regulated product categories and is often cited as a model for efficient small-population national regulators.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/saudi_fda
• LinkedInlinkedin.com/company/sfda

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Saudi Food & Drug Authority